Stock Market Outlook: Dow, S&P 500, Nasdaq Face Headwinds Amidst US-Iran Tensions
New York – US stock markets, which experienced a moderate recovery mid-week, are poised for potential declines on Thursday as investor sentiment is dampened by ongoing uncertainties surrounding the conflict between the United States and Iran. The situation remains fluid, with a lack of confirmed progress in diplomatic efforts weighing heavily on market confidence.
Market Performance & Investor Sentiment
As of 9:45 AM EDT, the Dow Jones Industrial Average is projected to open down 0.8% at 46,060 points. The Nasdaq 100, heavily weighted towards technology stocks, is expected to fall 1.1% to 23,905 points, according to broker IG. Yahoo Finance reports these pre-market declines reflect growing investor impatience with the stalled peace process.
Iran Rejects US Proposal for Ceasefire
Despite US government statements to the contrary, Iranian Foreign Minister Abbas Araghchi has publicly denied any ongoing negotiations with Washington to finish the conflict. Araghchi stated on state television, “I firmly declare that there were no negotiations or discussions with the American side,” and further rejected any potential talks. Seeking Alpha highlights this rejection as a key driver of Thursday’s market downturn.
Impact on Key Sectors
The technology sector is particularly vulnerable, with all seven companies comprising the “Magnificent Seven” – Apple, Nvidia, Meta, and Microsoft – expected to experience losses. Nvidia, Meta, and Microsoft are projected to fall more than one percent before market open. Energy stocks, however, are seeing gains, while US mining stocks are declining, influenced by President Trump’s warnings regarding Iran.
Other Market Movers
- Equitable Holdings & Corebridge Financial: Shares of both US insurance companies rose by over 2% in pre-market trading following the announcement of a $22 billion merger via a share swap.
- Olaplex: Shares jumped approximately 50% before the start of the market after German consumer goods group Henkel agreed to acquire the shampoo maker for $1.4 billion.
- Kodiak Sciences & Precigen: Both companies experienced significant gains – around 50% and 23% respectively – driven by positive Phase III study data for Kodiak Sciences’ diabetic retinopathy treatment and strong revenue projections for Precigen’s Papzimeos drug.
Oil Prices and Economic Concerns
Portfolio manager Thomas Altmann from QC Partners warned that prolonged delays in achieving peace will continue to exert upward pressure on oil prices, ultimately damaging the global economy. The longer the peace process drags on, the greater the potential for economic disruption.
This is a developing story and will be updated as more information becomes available.
Worth a look